The covalent binding of bromobenzene with nucleic acids
Related Experiment Video
Updated: Aug 8, 2026

Analyzing and Building Nucleic Acid Structures with 3DNA
Published on: April 26, 2013
Abstract:
The hepatotoxic compound bromobenzene binds to DNA, RNA, and proteins of rat and mouse liver in vivo. Binding to a significant extent is also detected in mouse kidney. The covalent binding index (CBI) of bromobenzene is comparable to CBI values of moderately oncogenic substances. The enzyme-mediated in vitro interaction of bromobenzene with calf thyumus DNA and synthetic polyribonucleotides is effected only by microsomes, especially those from mouse and rat liver. Microsomes from mouse lung are also efficient in bioactivating bromobenzene to interact with DNA. Among polyribonucleotides, poly(G) and poly(A) are the most labeled substrates. The suppression of binding to DNA by SKF 525-A and the induction of microsomal activity by a pretreatment with phenobarbitone in vivo confirm that bromobenzene is bioactivated by a P-450 dependent-microsomal mixed function oxidase system. The covalent binding can be the main event to determine the possible carcinogenicity by genotoxic mechanisms. Bromobenzene is photoactivated by ultraviolet light (lambda = 254 nm) to forms capable of interacting with DNA in vitro; the binding is linear up to time.
Insights
Hepatotoxic bromobenzene binds to DNA and proteins in rat and mouse liver and kidney. This covalent binding, mediated by a P-450 enzyme system, suggests potential genotoxic carcinogenicity.
Area of Science:
- Toxicology
- Biochemistry
- Carcinogenesis
Background:
- Hepatotoxic compounds can exert toxicity through covalent binding to cellular macromolecules.
- Bromobenzene is a known hepatotoxic agent, but its interaction with DNA and the mechanisms involved require further elucidation.
Purpose of the Study:
- To investigate the in vivo and in vitro binding of bromobenzene to DNA, RNA, and proteins.
- To identify the enzymatic systems responsible for bromobenzene bioactivation.
- To assess the potential genotoxic mechanisms underlying bromobenzene's carcinogenicity.
Main Methods:
- In vivo and in vitro covalent binding assays using radiolabeled bromobenzene.
- Analysis of binding in liver, kidney, and lung tissues of rats and mice.
- Enzymatic bioactivation studies using liver microsomes and specific enzyme inhibitors (SKF 525-A) and inducers (phenobarbitone).
- Photoactivation studies using ultraviolet light.
Main Results:
- Bromobenzene demonstrated significant covalent binding to DNA, RNA, and proteins in rat and mouse liver, and to a lesser extent in mouse kidney.
- Enzyme-mediated bioactivation occurred primarily via a P-450 dependent-microsomal mixed-function oxidase system, particularly in liver and lung microsomes.
- Poly(G) and poly(A) were the most reactive synthetic polynucleotides.
- Ultraviolet light also induced DNA-reactive forms of bromobenzene.
Conclusions:
- Bromobenzene's covalent binding to macromolecules, especially DNA, is mediated by a P-450 system, indicating a potential genotoxic mechanism for its carcinogenicity.
- The covalent binding index (CBI) suggests bromobenzene may be a moderately oncogenic substance.
- Both metabolic and photoactivation pathways contribute to bromobenzene's DNA-reactive potential.
More Related Videos
Related Concept Videos
Halogenation of Alkenes
Consider the bromination of cyclopentene. Molecular bromine is polarized in the proximity of the π electrons of cyclopentene. An electrophilic bromine atom adds across the double bond, forming a cyclic bromonium ion intermediate.
Structure of Benzene: Molecular Orbital Model
Nucleophilic Aromatic Substitution: Elimination–Addition
NMR Spectroscopy of Benzene Derivatives
Electrophilic Aromatic Substitution: Chlorination and Bromination of Benzene
Spin–Spin Coupling Constant: Overview
Qualitatively, any spin plus-half nucleus polarizes the spins of its electrons to the minus-half state. Consequently, the paired electron in the hydrogen–carbon bond must have a...

